GLYC - GlycoMimetics Stock Trading

GlycoMimetics Inc.(NASDAQ: GLYC) stock trading, description, contact, officers and directors.

About GlycoMimetics Inc.

None

Stock Information

GlycoMimetics Inc. Company Name:

GLYC Stock Symbol:

NASDAQ Market:

GlycoMimetics Inc. Website:

Get GLYC Alerts

News, Short Squeeze, Breakout and More Instantly...

GLYC - Trial Launches to Evaluate GlycoMimetics' Uproleselan Added to Cladribine Plus Low-Dose Cytarabine in AML Patients

Trial to study uproleselan combination in patients with high-risk treated secondary AML GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that clinicians have treated the first patient in a Phase 1b/2 study evaluating the company’s lead drug candidate, uproleselan, a...
GLYC - GlycoMimetics Inc.: New 52-Week Low Set Today (GLYC)

GlycoMimetics Inc. (NASDAQ:GLYC) traded at a new 52-week low today of $1.96. So far today approximately 203,000 shares have been exchanged, as compared to an average 30-day volume of 663,000 shares. GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discove...
GLYC - GlycoMimetics Inc.: The Losing Streak Continues (GLYC)

Shares of GlycoMimetics Inc. (NASDAQ:GLYC) traded at a new 52-week low today of $2.02. This new low was reached on below average trading volume as 203,000 shares traded hands, while the average 30-day volume is approximately 684,000 shares. Potential upside of 1.8% exists for GlycoMimeti...